Making Pharmaceuticals Conference 2018

Keynote Speaker:

Mark Birse, Head of Inspectorate, MHRA:  Regulatory Futures

2018 Conference presentations:

  • GDP for Active Substances, Nick Carter, Wessex Fine Chemicals Limited
  • An Introduction to Good Manufacturing Practice, Dominic Parry, Inspired Pharma Training Ltd
  • Technology and Innovation, PuroVaso Limited
  • Latest Tablet 3D Laser Lettering and Inspection Technology, Cosa
  • Nano Milling: Advanced Technology for the New Nano Drug Era, Frewitt
  • Consigma Innovation and Award Winning Technology, GEA
  • Microbial Identification: Principles and Opportunities of using MALDI-ToF, Charlotte Byrne, STERIS
  • Good Manufacturing Practice – What is EU and USA GMP?, Dominic Parry, Inspired Pharma Training Ltd
  • Practical and Operational Challenges in the Manufacture of Cell Therapies, Radhika Shah, UCL Institute of Ophthalmology
  • Modifying Human Behaviour for Perpetual GMP Compliance, John Johnson, NSF Health Sciences
  • Global Serialisation Requirements: The Pathway to Successful Serialisation Implementation, Nigel Banfield, Wipotec OCS Ltd
  • Enhanced Residual Solvents Analysis: A Practical Approach to Sampling, Transport, Storage and Analysis, Daniel Moreland, Butterworth Laboratories Ltd
  • BREXIT-Are You Ready?, Lynne Byers, NSF Health Sciences
  • Auditing API Suppliers in India, Mukesh Patel, CommQP Ltd
  • Correlated Chemical and Morphology Imaging to Investigate Formulation Dissolution, Dr Hazel Garvie-Cook, Renishaw
  • Shedding Light on Macromolecule Characterisation, Ross Blezard, Reading Scientific Services Ltd
  • Applications of PTR-MS in Over-The-Counter Medications, Donna Byrom, Reading Scientific Services Ltd
  • Chemical Analysis of Medicinal Products, Medical Devices and API Distribution in Ex-Vivo Models by Mass Spectrometry Imaging, Dr Elzbieta Gurdak, National Physical Laboratory
  • Quality Risk Management – Making It Work For You, Kate Krachai, Quality Context
  • Permitted Daily Exposure Approach when Determining Limit Settings for Residues (Detergent), Thomas Altmann, Ecolab
  • The Making Pharmaceuticals Recipe for Success, Matt Burton, JensonR+
  • Building Robust Advanced Therapy Value Chains with Rapid Prototyping and Systems Thinking, Hedley Rees, Pharmaflow Ltd
  • Preparation and Execution of a Factory Acceptance Test (FAT), Olivier Van Houtte, STERIS Corporation
  • How to Achieve EU-FMD Compliance in Under 9 Months, Dan Anslow, Crest Solutions
  • Combinational Approach for Advanced Understanding of a Capsule Filling Process for Inhalation Application, Eva Faulhammer, RCPE Graz
  • Expanded Design Space in Hot Melt Extrusion with High Productivity Hypromellose Acetate Succinate, Dr Meinolf Brackhagen
  • Pharmaceutical Double-Coated Floating Pellets, Mohammed Dahmash, University of Sunderland
  • Phospholipids as Business Opportunities for Pharmaceutical Line Extension Products, Dr Christophe Heuberger, Lipoid AG
  • Influence of Process Parameters On In-line Particle Size Measurement for Fluidized Bed Granulation, Theresa Reimers, Glatt GmbH
  • Think Like Bacteria, Commercial Manager, Technomek
  • Research and Development of Natural Resources: The Nagoya Protocol, Simon Trevenna, Department for Business, Energy and Industrial Strategy (BEIS)
  • EU FMD: The Challenge for Verifiers, Steve Moffatt, Innovate UK / Manchester University
  • The Benefits of Micronised Particle Technology for Film Coating, Dr Enosh Mesigwa, Azelis
  • Unique Silica Microspheres for Difficult to Formulate Actives and Excipients, Richard Summers, Azelis
  • The Use of Dextrates in a Lactose-free Reformulation of Cetirizine Tablets, Hannah Bogner, JRS Pharma GmbH & Co. KG
  • WFI Production with Reverse Osmosis-Based System, James Steptoe, Veolia Water Technologies
  • The Complete Data Integrity Solution – From Balance to Backup, Dave Houlker, Shimadzu UK Ltd
  • Humidity Control for Optimal Production of Solid Dosage Forms and GMP Compliance, Martin Ginty, Munters
  • Microbiological Considerations in Cleanroom Validation, John McKenzie, Wickham Laboratories Ltd
  • Improving Biologics Downstream Operation Through Formulation Innovation, John Liddel
  • Development of Open Access Pilot Line for Targeted Drug Delivery
  • GDPR – Its Effect on Clinical Trials
  • Can Technology Replace CRA’s and is Amazon Poised to be the Mega CRO
  • The Data Integrity of the Electronic Trial Master File
  • RISK
  • DIGA, a Methodology for Root Cause Analysis
  • Serialisation and Product Security, Nick Robbins
  • Manufacturing Challenges: Dusty Dusty: How DExToRR Can Help You Not to Explode, Keith Plumb
  • Validation, Karen Stevenson
  • Organisational Culture, Bob Hayes
  • Outsourcing of Engineering services for Pharmaceutical Businesses.  The Customer’s Tale, Simon Shelly
  • Outsourcing of Engineering Services for Pharmaceutical Businesses.  The Supplier’s Tale, Michael Harris
  • e-Commerce in Pharmaceuticals, Claire Edwards
  • Life Sciences & Healthcare, H Meese
  • New Views – The Circular Economy and Pharmaceuticals, Phillipa Oldham
  • EU Futures Medicines Directive Regulation
  • Child Safe Packaging
  • The Cost of Marketing Supply Chain Inefficiency
  • EU Medical Devices Regulations – An Update on Latest Status and Implications for Combination Products
  • Connecting the Disconnected: Overcoming the Disconnects Within Your Labelling Supply Chain That Risk Compliance
  • Disruptive Innovation – a Bitter Sweet Pill to Swallow
  • Patient Adherence and the Ability of Packaging Systems to Grow Patient Adherence Through Smart and Smarter Packaging

Seerpharma

  • Managing CAPA
  • Effective Root Cause Analysis
  • Risk Management, Are You Doing it Effectively?
  • Process Analytical Technology and Continued Process Verification
  • EU GMP Annex 1 Update for Sterile Manufacture– Where Are We Now?
  • Cleanroom Behaviour and Aseptic Practices
  • Understanding and Control of the Supply Chain – are We There Yet?
  • PQG/ ECA’s GDP guide – Latest Developments

 

  • The 2017 Edition of the EXCiPACT GMP and GDP Standards: Key Changes, Dr Iain Moore, Croda International
  • EXCiPACT: Taking an Idea to Global Reality, Tony Scott

De Montfort University

  • The Advantages of Using a Continuous Manufacturing Processes During Medicines Development AND Commercial Supply, Professor Gordon Muirhead
  • The Use of an Adaptive Rapid Development Platform in the Development of Medicines, Professor Gordon Muirhead
  • Enhancing Continuous Process Understanding with In-line Analytical Technologies: a Case Study Using UV-Vis Spectroscopy, Prof Walkiria Schlindwein
  • Breathing Easy: Modern Inhaled Medicines to Treat Respiratory Diseases, Dr Helen Muirhead
  • New IPEC Guideline : Quality Agreement Guide and Template(s), Iain Moore, Croda, UK
  • Excipient Functionality Related Characteristics, Liz Meehan, AstraZeneca
  • Novel Excipients, Christian Becker, BASF, Germany